News & Events
January 1, 2021
Our Leducq Cytoskeletal Network has begun!
On January 1st 2021 we officially kicked off the Leducq Cytoskeletal Network (LCN). This Trans-Atlantic Network of Excellence brings together 7 different labs from the U.S. and Europe all working to better understanding how the cytoskeleton contributes to normal and pathological functions of heart muscle cells, and to develop new therapies for the treatment of heart disease. The network will be led by Dr. Prosser from Penn and Dr. Lucie Carrier from Hamburg. For more details check out the press release under recent research.
Tags:
Related Posts
- Ben co-Chairing Cardiac Regulatory Mechanisms GRC ( March 5, 2024 )
- Scientist Shifts Focus to Daughter’s Rare Disease ( April 17, 2023 )
- $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders ( February 8, 2023 )
- Collaboration with Ionis Pharmaceuticals on new therapies for neurodevelopment disorders ( November 23, 2020 )
- Congrats Julie on your cover story in Circ Res! ( January 22, 2020 )
- Matt’s work on microtubules in diastolic dysfunction published in Circulation! ( November 22, 2019 )
- Press for Chen et al., Nature Med 2018 ( September 29, 2018 )
- Prosser lab work published in Nature Medicine! ( June 11, 2018 )
- Ben wins AHA Outstanding Early Career Investigator Award ( July 25, 2017 )
- Welcome Alex S! ( March 23, 2017 )
Recent Posts
- Ben co-Chairing Cardiac Regulatory Mechanisms GRC
- Scientist Shifts Focus to Daughter’s Rare Disease
- $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders
- Our Leducq Cytoskeletal Network has begun!
- Collaboration with Ionis Pharmaceuticals on new therapies for neurodevelopment disorders
Recent Comments
No comments to show.